|
End-of-day quote
Egyptian Exchange
19/11/2026
|
5-day change | 1st Jan Change | ||
| 773.08 EGP | -0.88% |
|
-2.47% | +121.39% |
Company Valuation: MINAPHARM Pharmaceuticals
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 987 | 1,303 | 1,822 | 2,408 | 1,796 | 4,114 |
| Change | - | 32.02% | 39.82% | 32.19% | -25.41% | 129.01% |
| Enterprise Value (EV) 1 | 922 | 1,570 | 2,562 | 4,297 | 4,395 | 5,224 |
| Change | - | 70.23% | 63.21% | 67.74% | 2.27% | 18.88% |
| P/E | 3.28x | 2.91x | 2.88x | -43.5x | 14x | 584x |
| PBR | 0.64x | 0.69x | 0.55x | 0.7x | 0.44x | 0.66x |
| PEG | - | 0.1x | 0.1x | 0x | -0x | -6.2x |
| Capitalization / Revenue | 0.42x | 0.43x | 0.5x | 0.62x | 0.32x | 0.64x |
| EV / Revenue | 0.39x | 0.52x | 0.71x | 1.1x | 0.78x | 0.81x |
| EV / EBITDA | 1.48x | 1.89x | 2.36x | 8.02x | 3.75x | 3.87x |
| EV / EBIT | 1.71x | 2.1x | 2.66x | 11.5x | 4.71x | 5.13x |
| EV / FCF | 3.33x | -10.9x | -4.11x | -3.25x | -10.3x | -28.5x |
| FCF Yield | 30.1% | -9.18% | -24.3% | -30.7% | -9.71% | -3.51% |
| Dividend per Share 2 | 2.7 | 2.922 | 2.8 | 1.65 | 2.5 | - |
| Rate of return | 3.36% | 2.76% | 1.89% | 0.76% | 1.54% | - |
| EPS 2 | 24.47 | 36.42 | 51.41 | -5.006 | 11.58 | 0.5979 |
| Distribution rate | 11% | 8.02% | 5.45% | -33% | 21.6% | - |
| Net sales 1 | 2,361 | 3,005 | 3,621 | 3,892 | 5,665 | 6,438 |
| EBITDA 1 | 621.7 | 828.5 | 1,086 | 536 | 1,172 | 1,348 |
| EBIT 1 | 538.8 | 746.5 | 964.7 | 374.7 | 933.8 | 1,019 |
| Net income 1 | 300.8 | 466.4 | 612.7 | -31.99 | 157.1 | 40.22 |
| Net Debt 1 | -65.01 | 266.5 | 739.6 | 1,889 | 2,598 | 1,110 |
| Reference price 2 | 80.29 | 106.00 | 148.21 | 217.68 | 162.36 | 349.20 |
| Nbr of stocks (in thousands) | 12,293 | 12,293 | 12,293 | 11,064 | 11,064 | 11,781 |
| Announcement Date | 30/03/21 | 30/03/22 | 29/03/23 | 06/04/24 | 11/06/25 | 09/06/26 |
1EGP in Million2EGP
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 169M | ||
| 39.41x | 13.36x | 28.32x | 0.51% | 1,200B | ||
| 36.94x | 6.65x | 18.71x | 1.97% | 651B | ||
| 36.49x | 8.39x | 17.36x | 2.41% | 506B | ||
| 21.41x | 5.17x | 12.95x | 2.53% | 377B | ||
| 94.91x | 5.47x | 23.3x | 2.54% | 330B | ||
| 22.98x | 5.56x | 13.52x | 2.87% | 288B | ||
| 23.04x | 4.63x | 13.15x | 1.9% | 272B | ||
| 22.71x | 6.96x | 12.8x | 2.32% | 236B | ||
| -39.14x | 7.25x | 45.66x | 1.98% | 206B | ||
| Average | 28.75x | 7.05x | 20.64x | 2.11% | 407B | |
| Weighted average by Cap. | 34.26x | 8.45x | 21.50x | 1.77% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MIPH Stock
- Valuation MINAPHARM Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
















